Cargando…

Metabolic requirements for cancer cell proliferation

BACKGROUND: The study of cancer metabolism has been largely dedicated to exploring the hypothesis that oncogenic transformation rewires cellular metabolism to sustain elevated rates of growth and division. Intense examination of tumors and cancer cell lines has confirmed that many cancer-associated...

Descripción completa

Detalles Bibliográficos
Autores principales: Keibler, Mark A., Wasylenko, Thomas M., Kelleher, Joanne K., Iliopoulos, Othon, Vander Heiden, Matthew G., Stephanopoulos, Gregory
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4989334/
https://www.ncbi.nlm.nih.gov/pubmed/27540483
http://dx.doi.org/10.1186/s40170-016-0156-6
_version_ 1782448551844904960
author Keibler, Mark A.
Wasylenko, Thomas M.
Kelleher, Joanne K.
Iliopoulos, Othon
Vander Heiden, Matthew G.
Stephanopoulos, Gregory
author_facet Keibler, Mark A.
Wasylenko, Thomas M.
Kelleher, Joanne K.
Iliopoulos, Othon
Vander Heiden, Matthew G.
Stephanopoulos, Gregory
author_sort Keibler, Mark A.
collection PubMed
description BACKGROUND: The study of cancer metabolism has been largely dedicated to exploring the hypothesis that oncogenic transformation rewires cellular metabolism to sustain elevated rates of growth and division. Intense examination of tumors and cancer cell lines has confirmed that many cancer-associated metabolic phenotypes allow robust growth and survival; however, little attention has been given to explicitly identifying the biochemical requirements for cell proliferation in a rigorous manner in the context of cancer metabolism. RESULTS: Using a well-studied hybridoma line as a model, we comprehensively and quantitatively enumerate the metabolic requirements for generating new biomass in mammalian cells; this indicated a large biosynthetic requirement for ATP, NADPH, NAD(+), acetyl-CoA, and amino acids. Extension of this approach to serine/glycine and glutamine metabolic pathways suggested lower limits on serine and glycine catabolism to supply one-carbon unit synthesis and significant availability of glutamine-derived carbon for biosynthesis resulting from nitrogen demands alone, respectively. We integrated our biomass composition results into a flux balance analysis model, placing upper bounds on mitochondrial NADH oxidation to simulate metformin treatment; these simulations reproduced several empirically observed metabolic phenotypes, including increased reductive isocitrate dehydrogenase flux. CONCLUSIONS: Our analysis clarifies the differential needs for central carbon metabolism precursors, glutamine-derived nitrogen, and cofactors such as ATP, NADPH, and NAD(+), while also providing justification for various extracellular nutrient uptake behaviors observed in tumors. Collectively, these results demonstrate how stoichiometric considerations alone can successfully predict empirically observed phenotypes and provide insight into biochemical dynamics that underlie responses to metabolic perturbations. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s40170-016-0156-6) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-4989334
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-49893342016-08-19 Metabolic requirements for cancer cell proliferation Keibler, Mark A. Wasylenko, Thomas M. Kelleher, Joanne K. Iliopoulos, Othon Vander Heiden, Matthew G. Stephanopoulos, Gregory Cancer Metab Research BACKGROUND: The study of cancer metabolism has been largely dedicated to exploring the hypothesis that oncogenic transformation rewires cellular metabolism to sustain elevated rates of growth and division. Intense examination of tumors and cancer cell lines has confirmed that many cancer-associated metabolic phenotypes allow robust growth and survival; however, little attention has been given to explicitly identifying the biochemical requirements for cell proliferation in a rigorous manner in the context of cancer metabolism. RESULTS: Using a well-studied hybridoma line as a model, we comprehensively and quantitatively enumerate the metabolic requirements for generating new biomass in mammalian cells; this indicated a large biosynthetic requirement for ATP, NADPH, NAD(+), acetyl-CoA, and amino acids. Extension of this approach to serine/glycine and glutamine metabolic pathways suggested lower limits on serine and glycine catabolism to supply one-carbon unit synthesis and significant availability of glutamine-derived carbon for biosynthesis resulting from nitrogen demands alone, respectively. We integrated our biomass composition results into a flux balance analysis model, placing upper bounds on mitochondrial NADH oxidation to simulate metformin treatment; these simulations reproduced several empirically observed metabolic phenotypes, including increased reductive isocitrate dehydrogenase flux. CONCLUSIONS: Our analysis clarifies the differential needs for central carbon metabolism precursors, glutamine-derived nitrogen, and cofactors such as ATP, NADPH, and NAD(+), while also providing justification for various extracellular nutrient uptake behaviors observed in tumors. Collectively, these results demonstrate how stoichiometric considerations alone can successfully predict empirically observed phenotypes and provide insight into biochemical dynamics that underlie responses to metabolic perturbations. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s40170-016-0156-6) contains supplementary material, which is available to authorized users. BioMed Central 2016-08-18 /pmc/articles/PMC4989334/ /pubmed/27540483 http://dx.doi.org/10.1186/s40170-016-0156-6 Text en © The Author(s). 2016 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Keibler, Mark A.
Wasylenko, Thomas M.
Kelleher, Joanne K.
Iliopoulos, Othon
Vander Heiden, Matthew G.
Stephanopoulos, Gregory
Metabolic requirements for cancer cell proliferation
title Metabolic requirements for cancer cell proliferation
title_full Metabolic requirements for cancer cell proliferation
title_fullStr Metabolic requirements for cancer cell proliferation
title_full_unstemmed Metabolic requirements for cancer cell proliferation
title_short Metabolic requirements for cancer cell proliferation
title_sort metabolic requirements for cancer cell proliferation
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4989334/
https://www.ncbi.nlm.nih.gov/pubmed/27540483
http://dx.doi.org/10.1186/s40170-016-0156-6
work_keys_str_mv AT keiblermarka metabolicrequirementsforcancercellproliferation
AT wasylenkothomasm metabolicrequirementsforcancercellproliferation
AT kelleherjoannek metabolicrequirementsforcancercellproliferation
AT iliopoulosothon metabolicrequirementsforcancercellproliferation
AT vanderheidenmatthewg metabolicrequirementsforcancercellproliferation
AT stephanopoulosgregory metabolicrequirementsforcancercellproliferation